MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials.
Paiva B, Manrique I, Dimopoulos MA, Gay F, Min CK, Zweegman S, Špička I, Teipel R, Mateos MV, Giuliani N, Cavo M, Hopkins CR, Fu W, Suryanarayan K, Vorog A, Li C, Wang B, Estevam J, Labotka R, Dash AB.
Paiva B, et al. Among authors: manrique i.
Blood. 2023 Feb 9;141(6):579-591. doi: 10.1182/blood.2022016782.
Blood. 2023.
PMID: 36130300
Free PMC article.